These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30187259)

  • 21. Lobe-Specific Lymph Node Dissection as a Standard Procedure in Surgery for Non-Small Cell Lung Cancer: A Propensity Score Matching Study.
    Adachi H; Sakamaki K; Nishii T; Yamamoto T; Nagashima T; Ishikawa Y; Ando K; Yamanaka K; Watanabe K; Kumakiri Y; Tsuboi M; Maehara T; Nakayama H; Masuda M
    J Thorac Oncol; 2017 Jan; 12(1):85-93. PubMed ID: 27553515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Worse Prognosis for Stage IA Lung Cancer Patients with Smoking History and More Severe Chronic Obstructive Pulmonary Disease.
    Yoshida Y; Kage H; Murakawa T; Sato Y; Ota S; Fukayama M; Nakajima J
    Ann Thorac Cardiovasc Surg; 2015; 21(3):194-200. PubMed ID: 25641032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic lymph node dissection is necessary for T1a non-small cell lung cancer.
    Liu T; Liu H; Li Y
    Asia Pac J Clin Oncol; 2015 Mar; 11(1):49-53. PubMed ID: 24787666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The prognostic impact of preoperative PET-CT on postoperative recurrence for completely resected stage I non-small cell lung cancer].
    Qiang G; Xu R; Liu J; Yan J; Xu Y; Di J; Da J; Liang C; Shi B; Guo Y; Liu D
    Zhonghua Wai Ke Za Zhi; 2015 Jul; 53(7):502-7. PubMed ID: 26359072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative bronchoscopic cancer confirmation does not increase risk of recurrence in stage1A non-small cell lung cancer.
    Abe J; Okazaki T; Kikuchi N; Takahashi S; Sakurada A; Okada Y
    Gen Thorac Cardiovasc Surg; 2018 May; 66(5):284-290. PubMed ID: 29564776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of COPD on pulmonary complications and on long-term survival of patients undergoing surgery for NSCLC.
    Sekine Y; Behnia M; Fujisawa T
    Lung Cancer; 2002 Jul; 37(1):95-101. PubMed ID: 12057873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of lobectomy on pulmonary function for early stage non-small cell lung cancer (NSCLC) patients with chronic obstructive pulmonary disease (COPD).
    Wei S; Chen F; Liu R; Fu D; Wang Y; Zhang B; Ren D; Ren F; Song Z; Chen J; Xu S
    Thorac Cancer; 2020 Jul; 11(7):1784-1789. PubMed ID: 32374491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COPD-related adenocarcinoma presents low aggressiveness morphological and molecular features compared to smoker tumours.
    Schiavon M; Marulli G; Nannini N; Pasello G; Lunardi F; Balestro E; Perissinotto E; Rebusso A; Saetta M; Rea F; Calabrese F
    Lung Cancer; 2014 Dec; 86(3):311-7. PubMed ID: 25454198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term surgical outcome in patients with lung cancer and coexisting severe COPD.
    Nakajima T; Sekine Y; Yamada Y; Suzuki H; Yasufuku K; Yoshida S; Suzuki M; Shibuya K; Fujisawa T; Yoshino I
    Thorac Cardiovasc Surg; 2009 Sep; 57(6):339-42. PubMed ID: 19707975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical treatment for lung cancer with COPD based on the Global Initiative for Chronic Obstructive Lung Disease (GOLD).
    Iwasaki A; Shirakusa T; Enatsu S; Maekawa S; Yoshida Y; Yoshinaga Y
    Thorac Cardiovasc Surg; 2005 Jun; 53(3):162-7. PubMed ID: 15926096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Smoking and smoking cessation in relation to the development of co-existing non-small cell lung cancer with chronic obstructive pulmonary disease.
    Zhai R; Yu X; Wei Y; Su L; Christiani DC
    Int J Cancer; 2014 Feb; 134(4):961-70. PubMed ID: 23921845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variations in surgeon treatment recommendations for lobectomy in early-stage non-small-cell lung cancer by patient age and comorbidity.
    Rogers SO; Gray SW; Landrum MB; Klabunde CN; Kahn KL; Fletcher RH; Clauser S; Tisnado D; Doucette W; Keating NL
    Ann Surg Oncol; 2010 Jun; 17(6):1581-8. PubMed ID: 20162461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reasonable extent of lymph node dissection in intentional segmentectomy for small-sized peripheral non-small-cell lung cancer: from the clinicopathological findings of patients who underwent lobectomy with systematic lymph node dissection.
    Matsumura Y; Hishida T; Yoshida J; Aokage K; Ishii G; Nagai K
    J Thorac Oncol; 2012 Nov; 7(11):1691-7. PubMed ID: 23059781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.
    Li Z; Yu Y; Lu J; Luo Q; Wu C; Liao M; Zheng Y; Ai X; Gu L; Lu S
    J Thorac Oncol; 2009 Jun; 4(6):702-9. PubMed ID: 19404215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma.
    Papi A; Casoni G; Caramori G; Guzzinati I; Boschetto P; Ravenna F; Calia N; Petruzzelli S; Corbetta L; Cavallesco G; Forini E; Saetta M; Ciaccia A; Fabbri LM
    Thorax; 2004 Aug; 59(8):679-81. PubMed ID: 15282388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for tumor recurrence in patients with early-stage (stage I and II) non-small cell lung cancer: patient selection criteria for adjuvant chemotherapy according to the seventh edition TNM classification.
    Maeda R; Yoshida J; Ishii G; Hishida T; Nishimura M; Nagai K
    Chest; 2011 Dec; 140(6):1494-1502. PubMed ID: 21622548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular characterization of chronic obstructive pulmonary disease-related non-small cell lung cancer through aberrant methylation and alterations of EGFR signaling.
    Suzuki M; Wada H; Yoshino M; Tian L; Shigematsu H; Suzuki H; Alaa M; Tamura H; Fujiwara T; Nagato K; Motohashi S; Moriya Y; Hoshino H; Yoshida S; Shibuya K; Hiroshima K; Nakatani Y; Yoshino I
    Ann Surg Oncol; 2010 Mar; 17(3):878-88. PubMed ID: 19841986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution of CD4(+) and CD8(+) T cells in tumor islets and stroma from patients with non-small cell lung cancer in association with COPD and smoking.
    Jackutė J; Žemaitis M; Pranys D; Šitkauskienė B; Miliauskas S; Bajoriūnas V; Sakalauskas R
    Medicina (Kaunas); 2015 Nov; 51(5):263-71. PubMed ID: 26674143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Survival after surgical treatment of bilateral synchronous multiple primary non-small cell lung cancers].
    Zhang ZR; Mao YS; Gao SG; Mu JW; Xue Q; Wang DL; Gao YS; Zhao J; He J
    Zhonghua Zhong Liu Za Zhi; 2016 Jun; 38(6):460-5. PubMed ID: 27346405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Curative treatment of Stage I non-small-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review.
    Palma D; Lagerwaard F; Rodrigues G; Haasbeek C; Senan S
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1149-56. PubMed ID: 21640513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.